News Releases | Insmed Incorporated

Month Year

Email Alerts

Jun 28, 2013

Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes

Read more
Jun 28, 2013

Insmed to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis

Read more
May 14, 2013

Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe

Read more
May 13, 2013

Insmed to Present at the UBS Global Healthcare Conference

Read more
May 10, 2013

Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Read more
May 7, 2013

Insmed Reports First Quarter Financial Results

Read more
May 1, 2013

Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013

Read more
Apr 18, 2013

Insmed to Present at the 12th Annual Needham Healthcare Conference

Read more
Apr 1, 2013

Insmed Appoints Matthew Pauls as Chief Commercial Officer

Read more
Mar 28, 2013

ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria

Read more
Mar 27, 2013

Insmed to Present at Future Leaders in the Biotech Industry Conference

Read more
Mar 18, 2013

Insmed Reports Fourth Quarter and Full Year 2012 Financial Results

Read more
Mar 11, 2013

Insmed to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013

Read more
Feb 26, 2013

Insmed to Present at Two Upcoming Investor Conferences

Read more
Feb 6, 2013

Insmed to Present at Two Upcoming Healthcare Investor Conferences

Read more
Dec 13, 2012

Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference

Read more
Nov 13, 2012

Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment

Read more
Nov 12, 2012

Insmed To Present At Two Upcoming Investor Conferences

Read more
Nov 7, 2012

Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer

Read more
Nov 7, 2012

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012

Read more
Oct 24, 2012

Insmed to Host 2012 Third Quarter Earnings Conference Call

Read more
Sep 28, 2012

Insmed Announces Pricing of Approximately $26 Million Direct Public Offering

Read more
Aug 30, 2012

Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

Read more
Aug 14, 2012

Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

Read more
Aug 7, 2012

Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation

Download

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Press Releases

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Footer